Alpine Associates Management »

ImmunoGen shares owned by Alpine Associates Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Alpine Associates Management from 13F filings

Historical chart of Alpine Associates Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Alpine Associates Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Alpine Associates Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $52M 1.8M 29.65

More positions owned by Alpine Associates Management

Hess (HES)
stock
Capri Holdings SHS (CPRI)
Amedisys (AMED)
Mirati Therapeutics
Albertsons Cos Common Stock (ACI)
Pioneer Natural Resources (PXD)
American Equity Investment Life Holding (AEL)
Sovos Brands
Karuna Therapeutics Ord
Cerevel Therapeutics Hldng I (CERE)
Silicon Motion Technology Sponsored Adr (SIMO)
ImmunoGen
Sp Plus (SP)
Rayzebio

View all positions for Alpine Associates Management

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen